Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Contributions to Nephrology|August 26, 2011
Biocompatible characteristics of high-performance membranesSusumu Uda, Masahide Mizobuchi, Tadao Akizawa
Clinical Kidney Journal|August 27, 2024
Association between CKD-MBD and hip-bone microstructures in dialysis patientsKen Iseri, Masahide Mizobuchi, Kanji Shishido, et al.
American Journal of Physiology. Renal Physiology|January 22, 2020
Early response of the parathyroid gland to withdrawal of a calcimimetic compound in uremic ratsMasahide Mizobuchi, Hiroaki Ogata, Fumihiko Koiwa, et al.
Bone|May 16, 2009
Vitamin D and vascular calcification in chronic kidney diseaseMasahide Mizobuchi, Hiroaki Ogata, Fumihiko Koiwa, et al.
American Journal of Nephrology|November 27, 2008
Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic ratsKazim Husain, Leon Ferder, Masahide Mizobuchi, et al.
Clinical and Experimental Nephrology|December 23, 2016
Research on kidney and mineral metabolism in Japan: past, present, and futureMasahide Mizobuchi, Hiroaki Ogata, Fumihiko Koiwa, et al.
NDT Plus|May 19, 2015
Clinical significance of parathyroid intervention on CKD-MBD managementHiroaki Ogata, Masahide Mizobuchi, Fumihiko Koiwa, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|August 24, 2017
RAS Inhibitor Is Not Associated With Cardiovascular Benefits in Patients Undergoing Hemodialysis in JapanMasahide Mizobuchi, Hiroaki Ogata, Yoshihiro Onishi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 7, 2023
Fibroblast Growth Factor 23 Exacerbates Cardiac Fibrosis in Deoxycorticosterone Acetate-Salt Mice With HypertensionTomohiro Saito, Masahide Mizobuchi, Tadashi Kato, et al.
Pageof 7